Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 mutations in breast cancer patients from north-east india

27Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Around 1.35 million people of worldwide suffer from breast cancer each year, whereas in India, 1 in every 17 women develops the disease. Mutations of the Breast Cancer 1 (BRCA1) gene account for the majority of breast/ ovarian cancer families. The purpose of study was to provide a prevalence of BRCA1 germline mutations in the North-East Indian population. In relation to the personal and family history with the breast cancer, we found mutations in 6.25% and 12.5% respectively. Three mutations, 185DelAG, 1014DelGT and 3889DelAG, were observed in our North-East Indian patients in exons 2 and 11, resulting in truncation of the BRCA1 protein by forming stop codons individually at amino acid positions 39, 303 and 1265. Our results point to a necessity for an extensive mutation screening study of high risk breast cancer cases in our North-East Indian population, which will provide better decisive medical and surgical preventive options.

Cite

CITATION STYLE

APA

Hansa, J., Kannan, R., & Ghosh, S. K. (2012). Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 mutations in breast cancer patients from north-east india. Asian Pacific Journal of Cancer Prevention, 13(11), 5871–5874. https://doi.org/10.7314/APJCP.2012.13.11.5871

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free